Moderna Stock News

The Cambridge-based company is studying the variant''s effects on those who received vaccines and booster shots. The data should be ready in a few weeks. The post Moderna chairman thinks vaccines might protect against omicron appeared first on Boston.com .

Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions in an effort to curb growing concern. The post Omicron strains worldwide Covid response appeared first on Khmer Times .

Tanner Davies receives a COVID-19 vaccination at a NOMI/TestUtah vaccination site in Lindon on Tuesday, Nov. 23, 2021. | Scott G Winterton, Deseret News Yes, new versions of the COVID-19 vaccines could be ready to take on the new omicron variant in the next 100 days or so. But no, Utahns shouldnt put off getting a booster shot against the deadly virus, an Intermountain Healthcare infectious diseases physician said Tuesday. Theres a lot of ifs there and right now, we are being challenged by delta, Dr. Eddie Stenehjem told reporters during a virtual news conference by the regions largest health care provider about the just discovered omicron variant of COVID-19 that has yet to be detected in the United States. Little is known about the omicron variant first identified in South Africa, including whether it is more transmissible, leads to more serious disease or is more resistant to the vaccines than the delta variant behind the surge in virus cases in Utah and other states that started over the summer.

BRUSSELS: Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EUs drug regulator said on Tuesday. The decision on whether new shots are required would, however, have to be made by other bodies, European Medicines Agency Executive Director Emer Cooke said. Were there a need to change the existing vaccines, we could be in a position to have those approved within three to four months, Cooke told a European Parliament committee. Thats from the start of the time when they would start to change. Her comments come after the head of US vaccine maker Moderna was quoted as saying that existing jabs will struggle against the heavily mutated Omicron. Moderna has already said it is working on an Omicron-specific vaccine, as is US rival Pfizer. Cooke said EU regulators dont know yet whether the current vaccines remain effective against Omicron which she said would take about two weeks to find out or whether new ones are needed. A decision needs to be made first whether thats necessary, and thats not a decision for the European Medicines Agency, Cooke said.

Moderna, Inc. (NASDAQ:MRNA) CEO Stephane Bancel sold 10,000 shares of Moderna stock in a transaction dated Friday, November 26th. The stock was sold at an average price of $319.62, for a total value of $3,196,200.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Stephane []

Lifesaving vaccines, an anti-tracking software and an electric mountain bike were among the breakthroughs honored in the 2021 Best of Whats New Awards from the magazine Popular Science . What Happened: The awards span 10 categories focusing on big picture concerns on health and the environment to individual distractions in entertainment and personal care. The magazine cited 10 products and technologies per category, totaling 100 citations for innovation. Despite the supply chain challenges making headlines in 2021, breakthroughs Full story available on Benzinga.com

Forex news for North American equities on November 30, 2021 Markets: - Gold down $12 to $1771 - US 10-year yields down 9 bps to 1.436% - WTI down $3.25 to $66.69 The tone for the day was set in Asia when Moderna''s CEO warned that the vaccines might not offer protection. Others pushed back against that idea and the mood was slowly improving early in US trade. By Adam Button

Bond exchange traded funds strengthened on Tuesday as concerns over the COVID-19 Omicron variant fueled the risk-off selling and investors headed toward safe havens. Traders turned away from risk assets toward safer bets after Modernas CEO warned of the risks involved with a spreading Omicron variant. There is no world, I think, where (the effectiveness) [] The post Bond ETFs Gain as Omicron, Inflation Concerns Drive Investors to Safety appeared first on ETF Trends .

Oil prices tumbled on Tuesday, with U.S. crude futures falling by more than 5%, after Moderna''s chief cast doubt on the efficacy of COVID19 vaccines against the Omicron coronavirus variant, spooking financial markets and heightening worries about oil demand.

Oil Crude prices got hit with a one-two punch from Moderna CEOs concern over the current MRNA vaccines effectiveness with Omicron and after the Fed sent the dollar higher and brought forward rate hike expectations. Energy traders will be stuck in wait-and-see mode over the next couple of weeks until a clearer picture emerges over []

Will New Jabs Be Necessary To Fight Omicron? Here Is Goldman''s Answer Over the weekend, Goldman Sachs'' analysts slammed the latest round of variant hysteria and insisted that the omicron variant will likely be remembered as a laughable sideshow, not unlike "Delta-plus". By Sunday night, the word had spread - don''t fall for the latest round of COVID variant FUD. It''s just one more tool for the Biden Administration and Dr. Anthony Fauci to push their own agenda while trying to frighten Americans into getting both the original jabs and their booster. In its latest note, the Goldman team started by ticking off a bunch of new stats about omicron that millions of Americans can probably site by memory at this point. The variant is roughly ~50 mutations, with ~30 on the Spike protein and ~10 on the receptor binding domain. A map of omicron''s mutations shows that the variant has several attributes believed to promote immune escape. However, this doesn''t necessarily guarantee that the variant will eventually replace delta as the most pervasive variant in the world.

World stocks and oil prices slid Tuesday after Moderna warned current vaccines might be less effective at fending off the Omicron variant, and eurozone inflation spiked to a record high.

The omicron Covid variant has changed the landscape for vaccine makers. Here''s how to trade Moderna stock now.

As if 2021 wasnt shaping up to be bountiful enough for Moderna (MRNA) stock, along comes another Covid-19 variant to alarm the global community but act as a spring

Whitney Tilsons email to investors discussing Moderna Inc (NASDAQ:MRNA) chief predicts existing vaccines will struggle with omicron; Nicholas Christakis thread; 88% of Americans are worried about inflation; Wage inflation is good; Krugman on inflation. Q3 2021 hedge fund letters, conferences and more Moderna Chief Predicts Existing Vaccines Will Struggle With Omicron 1) Stocks are selling []